Oct 10 (Reuters) - washington University in St. Louis:
* Says Roche drug gantenerumab, Eli Lilly's solanezumab chosen for
alzheimer's prevention trial -- Washington university
* Lilly beta secretase inhibitor also selected for potential inclusion
in global trial - Washington university
* Trial expected to begin early 2013 to test three drugs; each target
alzheimer's in different way -- Washington university
* Trial to be conducted at Washington university by dominantly inherited
alzheimer's network trials unit (dian tu) -- Washington university
* Trial to involve 160 people with inherited gene mutations that typically lead
to alzheimer's at young age -- Washington university
((New York Equities Desk; tel: +1 646 223 6000))
((For more news about ROCHE-LILLY click here: ))